WAM
IMCR icon

Wolverine Asset Management’s Immunocore IMCR Stock Holding History

Wolverine Asset Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-18,922
Closed -$598K – 1711
2024
Q3 		$589K Buy
+18,922
New +$688K 0.01% 823

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Wolverine Asset Management's IMCR Position: Q4 2024 in Review

Wolverine Asset Management sold out of Immunocore (IMCR) in Q4 2024, closing a stake of 18,922 shares — an estimated $598K sold.

Wolverine Asset Management first reported a position in IMCR in Q3 2024 and held it in 1 quarter. The position peaked at $589K in Q3 2024. 115 funds tracked by Wall St. Rank hold IMCR as of Q4 2024.

  • Wolverine Asset Management reported no remaining Immunocore position as of Q4 2024 after selling out during the quarter.
  • Wolverine Asset Management sold 18,922 Immunocore shares in Q4 2024, an estimated $598K.
  • Wolverine Asset Management first reported a position in Immunocore in Q3 2024 and held it in 1 quarter.
  • Wolverine Asset Management's Immunocore position peaked at $589K in Q3 2024.
  • 115 funds tracked by Wall St. Rank held Immunocore as of Q4 2024.

Based on Wolverine Asset Management's 13F filing for Q4 2024, filed 3 Feb 2025.